Navigation Links
ChemAxon Launches Marvin and JChem Version 5.1; Name to Structure Generation, OLE 2 and JavaScript Integration
Date:8/19/2008

BUDAPEST, Hungary, August 19 /PRNewswire/ -- ChemAxon, a software solutions provider for cheminformatics today announced the launch of version 5.1 of their cheminformatics toolkits, Marvin & JChem. As well as other improvements, the release sees the introduction of IUPAC name import, support for OLE 2 format useful for integrating with Microsoft Office applications.

Marvin & JChem is a software suite of application programming interfaces (API's) and graphic user interfaces (GUI's) used by life science informatics architects and developers to build chemically aware, platform independent and web ready enterprise informatics systems. Marvin includes structure and reaction editing, visualization and structure based property prediction; JChem includes structure management and search, library enumeration and library profiling.

A key development in the 5.1 release is the addition of name to structure generation in the IUPAC Naming Calculator Plugin allowing batches of chemical names to be stored as structures and found during chemical search. The new functionality is described and evaluated in a American Chemical Society National meeting presentation today (visit http://www.chemaxon.com/conf/IUPAC_N.pdf).

Improved integration features in the 5.1 release include OLE 2 support to extend interoperability with Microsoft Office applications and JavaScript support for ChemAxon's structure based calculation language, Chemical Terms. The JavaScript support can enable dynamic interaction between the Chemical Terms calculation and the drawn chemical structure, even during structure editing.

New search features include visualization and search of position variation bonds, useful in patent structure search as well as improvements in tautomer handling to give more correct results for registration and search.

To freely evaluate ChemAxon's Marvin, JChem and Instant JChem please visit our website.

About ChemAxon

ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit http://www.chemaxon.com.


'/>"/>
SOURCE ChemAxon Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ChemAxon Announces New CEO and Head of R&D
2. ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance
3. ChemAxon and Agilent Technologies Sign Agreement Extending JChem Integration With Kalabie Electronic Lab Notebook
4. ETEX Launches Innovative Osteoinductive Orthobiologic, EquivaBone(TM)
5. GEECF: Spectrum Launches Zero Waste Philippines and Gears Towards Cheap Green Energy
6. StollerUSA Launches Bio-Forge.com to Offer Solutions for Crops Under Stress
7. ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
8. Hooper Holmes Heritage Labs Division Launches New Home Diabetes Test
9. XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies
10. ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community
11. Ingenuity Systems Launches Analysis Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... ... Nipro Corporation (Osaka, Japan) and Transonic Systems Inc. (New York, USA) announced ... and sales rights for all non-OEM Transonic products in Japan. As partners for more ... Nipro - Transonic JV is a natural next step to advance best practices and ...
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, today presented data ... napabucasin, at the 2017 American Society of Clinical Oncology ... . In a Phase Ib/II ... designed to inhibit cancer stemness pathways by targeting STAT3 ...
(Date:1/20/2017)... MALDEN, MA (PRWEB) , ... ... ... the leader in Less Exposure Surgery (LES®) Technologies, announced today the next ... the PedFuse Pedicle Screw System platform). In contrast to the competition, SpineFrontier ...
(Date:1/19/2017)... 19, 2017 Research and Markets ... has announced the addition of the ... Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market trends ... using estimated market values as the base numbers Key ...
Breaking Biology Technology:
(Date:1/19/2017)... Calif. , Jan. 19, 2017 ... enhancing user experience and security for consumer electronics, ... next-generation payment processing systems and cybersecurity solutions, today ... banks, enterprises and financial institutions worldwide to bolster ... of the end-to-end secure user authentication platforms they ...
(Date:1/13/2017)... , Jan. 13, 2017 Sandata ... solutions for the homecare industry, including Electronic Visit ... industry expert, Justin Jugs, as Senior Vice President ... than 15 years of homecare experience to Sandata, ... developing strategic plans to align Sandata,s suite of ...
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... Forecasts, 2015 - 2022," projects that the global biometric technology market is expected to ... 2016 to 2022. Continue Reading ... ...      ...
Breaking Biology News(10 mins):